gdc
Cancer ResearchClinical TrialsImmunotherapy

Is CAR T-Cell Therapy Safe and Effective?

Claire White discusses the role of the FDA in evaluating new and promising treatments such as CAR T-cell therapy and the complexity of getting approvals.
Video Library – March 6, 2019
Claire White, BSN, RN, CPHON
The Children's Hospital of Philadelphia, Philadelphia, PA
Claire White discusses the role of the FDA in evaluating new and promising treatments such as CAR T-cell therapy and the complexity of getting approvals.
Recommended For You
Clinical Trials
Oncology Clinical Trials: Is It a Choice for You?
By Sharon S. Gentry, RN, MSN, AOCN, CBCN, HON-ONN-CG
Clinical trials can offer patients an investigational drug not yet widely available. Here’s what you need to know.
Immunotherapy
What Can You Expect with Cancer Immunotherapy?
By Bruce Gershenhorn, DO
Immunotherapy is offering exciting new treatments for many types of cancer. It works by revving up the immune system and can have various side effects in different patients.
Clinical Trials
Clinical Trials to Improve AYA Outcomes
By Michael E. Roth
Dr. Michael Roth believes that enhanced clinical trial enrollment will improve survival and quality of life for AYAs, and stresses the need to determine and overcome barriers to AYA clinical trial enrollment.
Clinical Trials
Why Are Clinical Trials Important in the Fight Against Cancer?
By Michael E. Roth
Dr. Michael Roth explains why clinical trials are critical to improving overall patient outcomes, including survivorship and quality of life.
Last modified: September 10, 2019

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country